Unjha Formulations Ltd
Incorporated in 1991, Unjha Formulations Ltd is a manufacturer and exporter of psyllium husk-based products.[1]
- Market Cap ₹ 9.50 Cr.
- Current Price ₹ 21.2
- High / Low ₹ 30.4 / 18.5
- Stock P/E 13.6
- Book Value ₹ 8.57
- Dividend Yield 0.00 %
- ROCE 27.8 %
- ROE 20.1 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- The company has delivered a poor sales growth of 9.60% over past five years.
- Promoter holding is low: 36.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.84 | 10.36 | 12.23 | 11.30 | 11.28 | 10.59 | 9.96 | 14.16 | 13.15 | 18.50 | 13.86 | 15.75 | |
| 8.65 | 10.00 | 11.86 | 10.96 | 10.98 | 10.34 | 9.83 | 13.84 | 12.71 | 17.93 | 13.34 | 14.64 | |
| Operating Profit | 0.19 | 0.36 | 0.37 | 0.34 | 0.30 | 0.25 | 0.13 | 0.32 | 0.44 | 0.57 | 0.52 | 1.11 |
| OPM % | 2.15% | 3.47% | 3.03% | 3.01% | 2.66% | 2.36% | 1.31% | 2.26% | 3.35% | 3.08% | 3.75% | 7.05% |
| 0.09 | 0.08 | 0.11 | 0.04 | 0.10 | 0.26 | 0.22 | 0.19 | 0.03 | 0.01 | 0.11 | 0.00 | |
| Interest | 0.01 | 0.10 | 0.10 | 0.02 | 0.01 | 0.12 | 0.17 | 0.13 | 0.06 | 0.05 | 0.01 | 0.01 |
| Depreciation | 0.09 | 0.08 | 0.09 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.10 | 0.14 |
| Profit before tax | 0.18 | 0.26 | 0.29 | 0.26 | 0.30 | 0.31 | 0.10 | 0.30 | 0.33 | 0.45 | 0.52 | 0.96 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | 15.15% | 40.00% | 23.08% | 26.04% |
| 0.17 | 0.26 | 0.30 | 0.26 | 0.30 | 0.31 | 0.10 | 0.25 | 0.28 | 0.28 | 0.41 | 0.70 | |
| EPS in Rs | 0.38 | 0.58 | 0.67 | 0.58 | 0.67 | 0.69 | 0.22 | 0.56 | 0.62 | 0.62 | 0.92 | 1.56 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 10% |
| 3 Years: | 6% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 48% |
| 3 Years: | 36% |
| TTM: | 71% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 20% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 14% |
| 3 Years: | 15% |
| Last Year: | 20% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 |
| Reserves | -4.09 | -3.83 | -3.54 | -3.27 | -2.97 | -2.67 | -2.56 | -2.31 | -2.03 | -1.75 | -1.34 | -0.64 |
| 0.40 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 2.51 | 2.28 | 2.79 | 2.75 | 2.15 | 1.90 | 1.61 | 1.28 | 0.96 | 2.20 | 1.42 | 1.67 | |
| Total Liabilities | 3.30 | 2.93 | 3.78 | 3.96 | 3.66 | 3.71 | 3.53 | 3.45 | 3.41 | 4.93 | 4.56 | 5.51 |
| 1.09 | 1.03 | 1.22 | 1.16 | 1.12 | 1.14 | 1.12 | 1.07 | 1.10 | 1.12 | 1.20 | 1.30 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2.21 | 1.90 | 2.56 | 2.80 | 2.54 | 2.57 | 2.41 | 2.38 | 2.31 | 3.81 | 3.36 | 4.21 | |
| Total Assets | 3.30 | 2.93 | 3.78 | 3.96 | 3.66 | 3.71 | 3.53 | 3.45 | 3.41 | 4.93 | 4.56 | 5.51 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.70 | 0.41 | 0.39 | 0.14 | -0.12 | 0.39 | -0.70 | 0.28 | -0.26 | 1.03 | -0.04 | 1.24 | |
| -0.09 | -0.02 | -0.28 | 0.06 | 0.04 | -0.10 | -0.06 | -0.02 | -0.10 | -0.11 | -0.18 | -0.23 | |
| 0.40 | -0.40 | 0.05 | -0.05 | 0.23 | 0.00 | 0.00 | 0.00 | -0.06 | -0.05 | -0.01 | -0.01 | |
| Net Cash Flow | -0.38 | -0.01 | 0.15 | 0.15 | 0.16 | 0.29 | -0.77 | 0.25 | -0.42 | 0.86 | -0.23 | 1.00 |
| Free Cash Flow | -0.78 | 0.39 | 0.11 | 0.20 | -0.08 | 0.29 | -0.76 | 0.26 | -0.36 | 0.92 | -0.22 | 1.01 |
| CFO/OP | -368% | 114% | 105% | 41% | -37% | 204% | -408% | 88% | -48% | 189% | 19% | 133% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28.08 | 28.54 | 19.40 | 25.19 | 43.36 | 39.64 | 35.91 | 18.04 | 29.14 | 31.76 | 39.77 | 31.29 |
| Inventory Days | 35.62 | 22.76 | 40.83 | 39.40 | 22.92 | 21.37 | 55.60 | 34.08 | 38.92 | 29.56 | 32.92 | 19.10 |
| Days Payable | 122.48 | 94.35 | 98.20 | 106.22 | 87.50 | 82.79 | 77.35 | 39.81 | 32.10 | 47.85 | 37.39 | 39.71 |
| Cash Conversion Cycle | -58.78 | -43.06 | -37.97 | -41.63 | -21.22 | -21.79 | 14.16 | 12.31 | 35.97 | 13.47 | 35.29 | 10.67 |
| Working Capital Days | -46.66 | -28.19 | -24.17 | -21.96 | -8.41 | -9.31 | 22.72 | 17.27 | 37.19 | 14.60 | 34.24 | 20.86 |
| ROCE % | 37.62% | 50.00% | 47.56% | 25.45% | 22.79% | 25.90% | 14.48% | 21.03% | 16.88% | 19.31% | 18.06% | 27.79% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Actual Production - Powder kg |
|
||||||||||
| Actual Production - Tablets Nos |
|||||||||||
| Number of Permanent Employees Numbers |
|||||||||||
| Installed Capacity - Powder Lacs kg |
|||||||||||
| Installed Capacity - Tablets Crores Nos |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Outcome Of Board Meeting - Appointment Of Company Secretary And Compliance Officer.
1 Jun - Board appointed Ms. Khushboo N Patel as Company Secretary and Compliance Officer effective 01 June 2026.
-
Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026
20 May - Newspaper pages contain unrelated articles; no clear company announcement.
-
Publish Audited Financial Results For The Quarter And Year Ended As On 31/03/2026
20 May - Unrelated newspaper content; no identifiable company announcement.
-
INTEGRATED FILING(FIN) FOR THE QUARTER AND YEAR ENDED 31/03/2026
18 May - Integrated financial filing submitted for quarter and year ended 31 March 2026.
-
Board Meeting Outcome for APPROVAL OF AUDITED FR FOR QUARTER AND YEAR ENDED AS ON 31.03.2026
18 May - Board approved audited FY2025-26 results and appointed secretarial auditor for 2025-26.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
UFL is a part of M/s Urvesh Ltd. It is a GMP-certified manufacturer and exporter of Isabgol (Psyllium) and Ayurvedic formulation products.
The company also manufactures all kinds of small-volume Ayurvedic Isabgol (Psyllium) powder.